MPCI
Cairo – Mubasher: Memphis Pharmaceutical and Chemical Industries said Thursday that it targets profits worth EGP 7 million for fiscal year 2017/2018, 75% up from an estimated profit of EGP 4 million for FY16/17.
The company’s plans to achieve revenues worth EGP 407 million in the next fiscal year, versus an estimated revenue of EGP 354 million for the current fiscal year, according to a bourse filing.
Memphis set the investment budget at EGP 13 million for FY17/18.
In the first eight months of FY16/17, profits increased 448% to EGP 3.3 million from EGP 602,000 for the same period of the previous year.
The stock stood at EGP 9.58 in Thursday’s early trading.